샘플 요청 목록

 카트 문의
시장보고서
상품코드
1545565

세계의 등온 핵산 증폭 기술(INAAT) 시장

Isothermal Nucleic Acid Amplification Technology (INAAT)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

등온 핵산 증폭 기술(INAAT) 세계 시장은 2030년까지 67억 달러에 달할 것으로 전망

2023년 34억 달러로 추정되는 등온 핵산 증폭 기술(INAAT) 세계 시장은 2023년부터 2030년까지 연평균 10.3% 성장하여 2030년에는 67억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 INAAT 시약은 CAGR 10.1%를 기록하여 분석 기간 종료 시점에 46억 달러에 달할 것으로 예상되며, INAAT 기기 부문은 분석 기간 동안 CAGR 10.7%로 성장할 것으로 예상됩니다.

미국 시장 8억 9,830만 달러로 추정, 중국은 CAGR 9.7%로 성장 전망

미국의 등온 핵산 증폭 기술(INAAT) 시장은 2023년 8억 9,830만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2023-2030년 분석 기간 동안 9.7%의 CAGR로 성장하여 2030년에는 10억 달러 규모에 이를 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 9.2%와 8.6%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 약 8.0%의 CAGR로 성장할 것으로 예상됩니다.

세계 등온 핵산 증폭 기술(INAAT) 시장 - 주요 동향 및 촉진요인 정리

등온 핵산 증폭 기술(INAAT)이 분자진단에 혁명을 가져올 이유는 무엇일까?

등온 핵산 증폭 기술(INAAT)은 열 사이클링이 필요 없는 신속하고 민감하며 특이적인 핵산 검출 방법을 제공함으로써 분자진단 분야에 혁명을 일으키고 있습니다. 기존 PCR 기술과 달리 INAAT는 일정한 온도에서 작동하기 때문에 필요한 장비가 간소화되고 결과 도출까지 걸리는 시간이 단축됩니다. 이 기술은 신속하고 정확한 진단이 필수적인 현장 진료 환경에서 특히 유용하며, INAAT는 감염성 질환, 유전성 질환, 암 바이오마커 검출에 널리 사용되어 현대 의료에 필수적인 도구로 자리매김하고 있습니다. 특히 고급 검사 인프라에 대한 접근성이 제한되어 있는 자원이 부족한 환경에서 일상적인 임상 진단에 도입이 진행되고 있습니다.

기술의 발전은 INAAT의 능력을 어떻게 향상시키고 있는가?

기술의 발전은 INAAT의 능력을 크게 향상시켜 더욱 견고하고, 다재다능하며, 사용하기 쉽게 만들었습니다. 효소 설계 및 반응 화학의 혁신은 INAAT 분석의 민감도와 특이성을 향상시켜 복잡한 생물학적 시료에서 낮은 수준의 핵산을 검출할 수 있게 했습니다. 또한, INAAT가 내장된 휴대가 간편하고 사용하기 쉬운 기기의 개발로 현장 진단 및 가정 내 검사에 대한 활용이 확대되고 있습니다. 이러한 발전은 신속하고 분산된 검사가 중요한 신종 감염병과의 싸움에서 특히 큰 영향을 미칩니다. 또한, INAAT와 디지털 기술 및 데이터 분석의 통합은 질병 발생의 실시간 모니터링과 개인 맞춤형 의료에 새로운 가능성을 제공하고 있습니다. 이러한 기술적 개선으로 공중보건에서 개인 맞춤형 의료에 이르기까지 다양한 분야에서 INAAT의 도입이 진행되고 있습니다.

INAAT 시장에는 어떤 도전과 기회가 존재할까?

INAAT의 채택이 확대되고 있음에도 불구하고, INAAT 시장은 표준화의 필요성, 규제 장벽, 기존 분자진단 기술과의 경쟁 등 여러 가지 도전에 직면해 있습니다. 서로 다른 INAAT 플랫폼 간에 표준화된 프로토콜과 시약이 없기 때문에 결과의 편차가 발생할 수 있으며, 이는 임상 적용에 있어 우려되는 부분입니다. 또한, 진단 검사에 대한 까다로운 규제 요건은 특히 미국이나 유럽과 같이 규제가 엄격한 시장에서는 INAAT 신제품의 상용화를 지연시킬 수 있습니다. 그러나 이러한 도전은 기술 혁신과 시장 성장의 기회가 될 수 있습니다. 표준화되고 사용하기 쉬운 INAAT 키트를 개발하여 광범위한 규제 당국의 승인을 받을 수 있는 기업들은 빠른 진단에 대한 수요 증가에 대응할 수 있을 것으로 보입니다. 또한, 감염병 대응, 암 검진, 개인 맞춤형 의료 등의 분야에서 진단 도구 개선에 대한 지속적인 요구가 INAAT에 대한 관심과 투자를 지속적으로 촉진하고 있습니다.

INAAT 시장 성장을 촉진하는 요인은 무엇인가?

등온 핵산 증폭 기술(INAAT) 시장의 성장은 신속하고 정확한 진단에 대한 수요 증가, 전염병 유행, 분자생물학의 발전 등 여러 가지 요인에 의해 주도되고 있습니다. 특히 COVID-19 팬데믹과 같은 세계 보건 위기 상황에서 현장 검사의 필요성이 증가하면서 신속하고 신뢰할 수 있는 진단 도구의 중요성이 부각되고 있으며, 이는 INAAT의 채택을 촉진하고 있습니다. 또한 종양학, 유전자 검사 등 INAAT의 용도가 감염성 질환 검사 외에도 확대되고 있는 점도 시장 성장에 기여하고 있으며, INAAT 플랫폼의 성능과 사용 편의성을 향상시키는 기술 발전은 임상 실험실에서 원격지까지 다양한 환경에서 폭넓게 채택될 수 있도록 하는 데 중요한 역할을 하고 있습니다. 헬스케어 시스템이 조기 진단과 맞춤 치료의 중요성을 계속 강조함에 따라 INAAT에 대한 수요는 더욱 확대될 것으로 예상되며, 이는 추가적인 발전과 시장 확장을 촉진할 것으로 전망됩니다.

조사 대상 기업 예시(주목할 만한 12개 기업)

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 성장 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 24.09.10

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Reach US$6.7 Billion by 2030

The global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$3.4 Billion in the year 2023, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. INAAT Reagents, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the INAAT Instruments segment is estimated at 10.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$898.3 Million While China is Forecast to Grow at 9.7% CAGR

The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$898.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 9.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.2% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.0% CAGR.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Key Trends & Drivers Summarized

Why Is Isothermal Nucleic Acid Amplification Technology (INAAT) Revolutionizing Molecular Diagnostics?

Isothermal Nucleic Acid Amplification Technology (INAAT) is revolutionizing the field of molecular diagnostics by providing a rapid, sensitive, and specific method for detecting nucleic acids without the need for thermal cycling. Unlike traditional PCR techniques, INAAT operates at a constant temperature, simplifying the equipment required and reducing the time to results. This technology is particularly valuable in point-of-care settings, where quick and accurate diagnostics are essential. INAAT is being widely adopted for the detection of infectious diseases, genetic disorders, and cancer biomarkers, making it an indispensable tool in modern healthcare. The technology's ability to deliver results quickly and with high accuracy is driving its integration into routine clinical diagnostics, especially in resource-limited settings where access to sophisticated laboratory infrastructure is limited.

How Are Technological Advancements Enhancing the Capabilities of INAAT?

Technological advancements are significantly enhancing the capabilities of INAAT, making it more robust, versatile, and accessible. Innovations in enzyme design and reaction chemistry are improving the sensitivity and specificity of INAAT assays, enabling the detection of low levels of nucleic acids in complex biological samples. Additionally, the development of portable and user-friendly devices that incorporate INAAT is expanding its use in field diagnostics and at-home testing. These advancements are particularly impactful in the fight against emerging infectious diseases, where rapid and decentralized testing is critical. The integration of INAAT with digital technologies and data analytics is also opening new possibilities for real-time monitoring of disease outbreaks and personalized medicine. These technological improvements are driving the adoption of INAAT across various sectors, from public health to personalized medicine.

What Challenges and Opportunities Exist in the INAAT Market?

Despite its growing adoption, the INAAT market faces several challenges, including the need for greater standardization, regulatory hurdles, and competition from established molecular diagnostics technologies. The lack of standardized protocols and reagents across different INAAT platforms can lead to variability in results, which is a concern for clinical applications. Additionally, the stringent regulatory requirements for diagnostic tests can slow down the commercialization of new INAAT products, particularly in highly regulated markets like the United States and Europe. However, these challenges also present opportunities for innovation and market growth. Companies that can develop standardized, easy-to-use INAAT kits with broad regulatory approval will be well-positioned to capitalize on the growing demand for rapid diagnostics. Moreover, the ongoing need for improved diagnostic tools in areas such as infectious disease control, cancer screening, and personalized medicine continues to drive interest and investment in INAAT.

What Factors Are Driving Growth in the INAAT Market?

The growth in the Isothermal Nucleic Acid Amplification Technology (INAAT) market is driven by several factors, including the increasing demand for rapid and accurate diagnostics, the rising prevalence of infectious diseases, and advancements in molecular biology. The ongoing need for point-of-care testing, particularly in the context of global health crises like the COVID-19 pandemic, has highlighted the importance of quick and reliable diagnostic tools, boosting the adoption of INAAT. Additionally, the expansion of INAAT applications beyond infectious disease testing, such as in oncology and genetic testing, is contributing to market growth. Technological advancements that improve the performance and ease of use of INAAT platforms are also playing a crucial role, as they enable wider adoption across different settings, from clinical laboratories to remote locations. As healthcare systems continue to emphasize the importance of early diagnosis and personalized treatment, the demand for INAAT is expected to grow, driving further advancements and market expansion.

Select Competitors (Total 12 Featured) -

  • Becton, Dickinson and Company
  • bioMerieux SA
  • Eiken Chemical Co., Ltd.
  • Lucigen Corporation
  • Meridian Bioscience, Inc.
  • Nugen Audio
  • QIAGEN GmbH
  • Ustar Biotechnologies (Hangzhou) Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages
    • Isothermal Nucleic Acid Amplification Technology (INAAT) - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Rapid Diagnostics Spurs Growth in INAAT Market
    • Advancements in Molecular Biology Propel Innovation in INAAT Applications
    • Growing Use of INAAT in Point-of-Care Testing Expands Addressable Market
    • Shift Towards Decentralized and Home-Based Testing Strengthens Business Case for INAAT
    • Increased Focus on Early Detection of Infectious Diseases Drives Adoption of INAAT
    • Technological Innovations in Isothermal Amplification Accelerate Market Growth
    • Rising Need for Portable and User-Friendly Diagnostic Tools Throws Spotlight on INAAT
    • Expanding Applications of INAAT in Oncology and Genetic Testing Generate New Opportunities
    • Shift Towards Personalized Medicine Drives Innovation in INAAT Applications
    • Rising Demand for Temperature-Sensitive Logistics Spurs Growth in Isothermal Packaging Market
    • Advancements in Insulation Materials Propel Innovation in Isothermal Packaging
    • Growing Use of Isothermal Packaging in Pharmaceutical and Biotechnology Expands Addressable Market
    • Shift Towards Sustainable Packaging Solutions Strengthens Business Case for Isothermal Packaging
    • Increased Focus on Cold Chain Integrity Drives Adoption of Isothermal Packaging
    • Technological Innovations in Passive and Active Cooling Systems Accelerate Market Growth
    • Rising Need for Safe Vaccine Distribution Throws Spotlight on Isothermal Packaging
    • Expanding Applications of Isothermal Packaging in Food and Beverage Industry Generate New Opportunities
    • Shift Towards E-commerce and Direct-to-Consumer Deliveries Drives Demand for Isothermal Packaging
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Blood Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Infectious Disease Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Infectious Disease Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Central & Reference Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Central & Reference Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • Active Players in United States
    • TABLE 32: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • Active Players in Japan
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • Active Players in China
    • TABLE 59: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • FRANCE
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • Active Players in France
    • TABLE 80: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • Active Players in Germany
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • Active Players in United Kingdom
    • TABLE 107: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Isothermal Nucleic Acid Amplification Technology (INAAT) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Disease Diagnostics, Blood Screening, Cancer and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Reagents and Instruments Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Reagents and Instruments for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospitals, Central & Reference Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Central & Reference Labs and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제